Evidence map›Paper›PMID 38027746›Full record

ArticleHeliyon2023

Synthesis and characterization of mesoporous bioactive glass nanoparticles loaded with peganum harmala for bone tissue engineering.

Maria Bibi, Syeda Ammara Batool, Sajid Iqbal, Shaher Bano Zaidi, Rabia Hussain, Memoona Akhtar, Ahmad Khan, Mohammed S Alqahtani, Mohamed Abbas, Muhammad Atiq Ur Rehman

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maria BibiDepartment of Materials Science and Engineering, Institute of Space Technology Islamabad, Islamabad 44000, Pakistan.
Syeda Ammara BatoolDepartment of Materials Science and Engineering, Institute of Space Technology Islamabad, Islamabad 44000, Pakistan.
Sajid IqbalDepartment of Nuclear and Quantum Engineering Korea Advanced Institute of Science and Technology (KAIST) 34141, Daejeon, Republic of Korea.
Shaher Bano ZaidiDepartment of Materials Science and Engineering, Institute of Space Technology Islamabad, Islamabad 44000, Pakistan.
Rabia HussainDepartment of Materials Science and Engineering, Institute of Space Technology Islamabad, Islamabad 44000, Pakistan.
Memoona AkhtarDepartment of Materials Science and Engineering, Institute of Space Technology Islamabad, Islamabad 44000, Pakistan.
Ahmad KhanDepartment of Materials Science and Engineering, Institute of Space Technology Islamabad, Islamabad 44000, Pakistan.
Mohammed S AlqahtaniRadiological Sciences Department, College of Applied Medical Sciences, King Khalid University, Abha 61421, Saudi Arabia.
Mohamed AbbasElectrical Engineering Department, College of Engineering, King Khalid University, Abha 61421, Saudi Arabia.
Muhammad Atiq Ur RehmanDepartment of Materials Science and Engineering, Institute of Space Technology Islamabad, Islamabad 44000, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, there is an increase in a number of bone disorders including osteoarthritis (OA), osteomyelitis, bone cancer, and etc., which has led to a demand for bone tissue regeneration. In order to take use of the osteogenic potential of natural herbs, mesoporous bioactive glass nanoparticles (MBGNs) have the ability to deliver therapeutically active chemicals locally. MBGNs influence bioactivity and osteointegration of materials making them suitable for bone tissue engineering (BTE). In the present study, we developed

Indexed as

AntibacterialBioactivityMesoporous bioactive glass nanoparticlesOsteomyelitisPeganum harmala

Identifiers

PMID38027746
PMCPMC10665746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.